Valfix Medical is a company headquartered in the United States.
Valfix Medical develops a minimally invasive transcatheter system to treat mitral regurgitation and heart failure by converting open-heart valve surgery into a less invasive procedure using a proprietary robotic interface.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.